Showing 2,121 - 2,140 results of 5,166 for search '(( significantly linear decrease ) OR ( significantly ((less decrease) OR (mean decrease)) ))', query time: 0.67s Refine Results
  1. 2121
  2. 2122
  3. 2123
  4. 2124
  5. 2125
  6. 2126
  7. 2127
  8. 2128
  9. 2129
  10. 2130
  11. 2131
  12. 2132
  13. 2133
  14. 2134

    Study data. by Jie Liu (15128)

    Published 2025
    “…</p><p> Conclusion </p><p>During the COVID-19 pandemic, both roxadustat and ESAs effectively improved renal anemia in PD patients, however, the roxadustat group experienced less additional costs for anemia correction and better medication compliance.…”
  15. 2135

    Summary of clinical outcomes after 9 months. by Jie Liu (15128)

    Published 2025
    “…</p><p> Conclusion </p><p>During the COVID-19 pandemic, both roxadustat and ESAs effectively improved renal anemia in PD patients, however, the roxadustat group experienced less additional costs for anemia correction and better medication compliance.…”
  16. 2136

    Approval by the research ethics committee. by Jie Liu (15128)

    Published 2025
    “…</p><p> Conclusion </p><p>During the COVID-19 pandemic, both roxadustat and ESAs effectively improved renal anemia in PD patients, however, the roxadustat group experienced less additional costs for anemia correction and better medication compliance.…”
  17. 2137
  18. 2138
  19. 2139
  20. 2140

    Risk Illustration. by Iftikhar Ali Ch (20783753)

    Published 2025
    “…Similarly, patients with EF > 40% had decreased incidence of SCD compared to those with EF < 40% (HR 0.347, 95% CI:0.158–0.763; p = 0.008). …”